Sign in

CIK 0000320017

  • Non-accelerated filer
  • Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222343568
Phone
+1 908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Grant or award See Remarks acquired 49,182 shares (grant or award)
  5. 4 Shares withheld for taxes Chief Executive Officer gave up 17,778 shares (to pay taxes)
  6. 4 Shares withheld for taxes See Remarks gave up 6,248 shares (to pay taxes)
  7. 4 Shares withheld for taxes SVP and CFO gave up 5,982 shares (to pay taxes)
  8. 4 Shares withheld for taxes See Remarks gave up 8,842 shares (to pay taxes)
  9. 4 Grant or award Director acquired 2,565 shares (grant or award)
  10. 4 Grant or award Director acquired 2,565 shares (grant or award)
  11. 4 Grant or award Director acquired 2,565 shares (grant or award)
  12. 4 Grant or award Director acquired 2,565 shares (grant or award)
  13. 4 Shares withheld for taxes SVP and CFO gave up 214 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Executive Officer gave up 690 shares (to pay taxes)
  15. 4 Shares withheld for taxes See Remarks gave up 224 shares (to pay taxes)
  16. 4 Shares withheld for taxes See Remarks gave up 247 shares (to pay taxes)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale Director sold 6,575 shares at $4.77 ($31,375)
  19. 4 Open-market sale Director sold 8,425 shares at an average $4.61 ($38,829)
  20. 4 Grant or award Director acquired 1,650 shares (grant or award)

Page 7 of 33 · 648 filings